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INTRODUCTION
The hepatitis B virus (HBV) affects approximately 350 million
peopleworldwide and causes a broad range of pathologies, includ-
ing chronic hepatitis B, hepatic cirrhosis, and hepatocellular carci-
noma (1). The HB vaccine, using recombinant HBV surface protein
antigen (HBsAg), is administered as a preventative measure to
health care workers with a high occupational risk of infection (2, 3).
However, individual differences in the immune response capability
to HB vaccination in healthy adults has been reported, with no im-
munological response, resulting in insufficient production of neu-
tralizing antibody, found in 5-10% of those vaccinated (4, 5). Both
exogenous and endogenous factors have been reported to underlie
this phenomenon (6, 7). Exogenous factors include : stress, nutri-
tional condition, cigarette smoking, and other infections ; and en-
dogenous factors include : sex, age, obesity, and genetic factors.
Indeed, investigation of HB vaccine-specific immune response in
twins revealed that genetic factors accounted for approximately
60% of the immune response to the vaccine (8). The influence of
the human leukocyte antigen (HLA) type, involved in antigen presen-
tation, has been identified as a major genetic factor, and many stud-
ies have reported the association between HLA type and immune
response to HB vaccine (4, 5, 9, 10). Cytokine gene polymorphisms
are also strongly suspected to influence immune response to the
vaccine due to their immunoregulatory functions (8). Indeed, HLA
type and cytokine gene polymorphisms have been identified as
independent factors (11). Cytokines function in various immune
responses, including antigen recognition, processing, and pres-
entation, antibody production and class switch, and regulation of
cytokine interaction. The association of interleukin (IL)-1β, IL-
10, tumor necrosis factor (TNF)-α, transforming growth factor
(TGF)-β, IL-13, and interferon (IFN)-γ gene polymorphisms with
immunological unresponsiveness to HB vaccination have been
reported mainly in western subjects (12-16).
A consensus has not yet been reached regarding these findings,
and there has been no study on genetic factors involved in the im-
mune response to HB vaccine in Japanese subjects. Therefore, the
aim of the present study, we investigated the association between
anti -HBs antibody production after HB vaccination and single nu-
cleotide polymorphisms (SNPs) of putative cytokine genes in Japa-
nese subjects. Since our preliminary study was not suggested this
association regarding SNPs in IL-1β, IL-13, and TGF-β, we fo-
cused on putative effect of cytokine genes on antibody production,
TNF-α, IL-10, and IFN-γ.
MATERIALS AND METHODS
The subjects were selected to minimize the influence of age, and
thus elucidate genetic factors of HB vaccine immune response in
a Japanese population. The subjects were 123 healthy, non-obese,
non-smoking, fourth-year student volunteers of the Laboratory of
Science, Saitama Prefectural University School of Health, and the
Department of Medical Technology, Kagawa Prefectural University
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of Health Sciences (26 males and 97 females ; age from 21 to 24
years old ; body mass index : BMI25.0 kg/m2). The objective
of the study was explained to participants, and consent for study
cooperation was obtained. This study was approved by the Ethics
Committees of Saitama Prefectural University and Kagawa Pre-
fectural University of Health Sciences, and written consent was
obtained from all participating subjects in accordance with the
Declaration of Helsinki.
The primary objective of the HB vaccination for the subjects was
to prepare them for clinical practice. They received the first, sec-
ond, and third administrations of yeast -derived recombinant HB
vaccine (Bimmugen ; The Chemo-Sero-Therapeutic Research
Inst.) in May, June, and November of their third year in school,
respectively. Blood samples for evaluation of the anti -HBs anti-
body level were collected in May of their fourth year ; thus, the
antibody level was measured approximately 6 months after the
third vaccination.Samples were collected in blood sampling tubes
with EDTA-2Na, plasma was separated by centrifugation, and
plasma HBs antibody was quantified by chemiluminescence en-
zyme immunoassay (CLEIA ; Fuji Rebio Inc.). When the antibody
level reached 1,000 mIU/ml or higher, the upper limit of the sam-
ple was determined using an enzyme linked immunosorbent assay
(ELISA ; Siemens Healthcare Japan Co., Ltd.). Genomic DNA was
extracted from buffy-coat white blood cells using a DNA extraction
kit (QIAamp DNA Blood mini kit ; QIAGEN Co., Ltd.).
SNPs of cytokine genes were detected by sequence-specific
primer (SSP)-polymerase chain reaction (PCR) or PCR-restriction
fragment length polymorphism (RFLP) analysis. The target cy-
tokine gene SNPs, PCR primer base sequences, and detection
method are shown in Table 1. The PCR reaction consisted of 100 ng
of genomic DNA as a template, 1PCR buffer (1.5 mM MgCl2),
200 μM dNTPs, 0.8 μM of each primer, 1U TaKaRa Ex Taq DNA
polymerase (TaKaRa Bio Inc.), and molecular grade water to a final
volume of 25 μl. All cycling conditions of PCR were as follows : an
initial denaturation at 95for 5 min, followed by 30 cycles at 95
for 30 sec denaturation, 55-64for 30 sec of primer annealing,
72for 30 sec extension, and a final extension step of 7 min at 72
in the last cycle. Amplified PCR products or restriction fragment
patterns were detected by 5% polyacrylamide gel electrophoresis.
Subjects were divided based on their anti -HBs antibody level
into low (10 mIU/ml), middle (10-100 mIU/ml), and high (100
mIU/ml) groups, and the detection frequencies of the SNP types
of the target genes were compared among the groups. The fre-
quencies of SNP genotypes and independence of each antibody
level group were analyzed using Fisher’s exact test. The Hardy-
Weinberg equilibrium (HWE) test for assessing the SNP genotype
frequency among subjects was conducted using a HWE calculator
including an analysis for ascertainment bias software (17). To con-
firm the individual factors, standardized residual analysis of SNP
genotypes was performed among three antibody level groups.
Results were expressed as the median values of anti -HBs antibody.
The anti -HBs antibody levels were normalized by logarithmic trans-
formation, differences among polymorphic groups were compared
using Kruskal -Wallis tests, and Mann-Whitney tests were used to
analyze differences between two polymorphic subgroups. Multiple
regression analyses were performed in order to ascertain involve-
ment in antibody production. StatFlex ver.6 (ArTec Co., Ltd.) soft-
ware was used to perform statistical analyses. P values (significance
probability)0.05 were considered as significant. Linkage dise-
quilibrium (LD) statistics were calculated using Haploview 4.2 (18).
RESULTS
Investigation of the influence of sex revealed that antibody levels
tended to be lower in male subjects (mean values of anti -HBs :
male ; 405.9113.2(SE) mIU/ml, female ; 479.9175.1(SE) mIU/
ml), but were not significantly different (P=0.11). Differences in
the genotype frequency and antibody level were observed in IL-10
(1082 ; rs1800629) and TNF-α (857 ; rs1799724) (P0.05). In
the other gene SNP types, a small, but non-significant, difference
in frequency was noted in IL-10 (819 ; rs1800871) (P=0.055). All
target SNP genotypes met the Hardy-Weinberg equilibrium prin-
ciple [Table 2]. When associations were investigated using stan-
dardized residual analysis, a significantly lower frequency was
observed with the IL-10 (1082) AA type (P0.01), and signifi-
cantly higher frequency was observed with the IL-10 (1082) AG
type (P0.05) in low antibody level group. A significantly higher
frequency was observed with the IL-10 (819) CT type (P0.05)
in low antibody level group. In addition, a significantly higher fre-
quency was observed with the TNF-α (857) CC type (P0.05)
in low and middle antibody level groups.
Table 1 Target cytokine gene SNPs, PCR primers and detection methods.




































UTR : untranslated region, SSP-PCR : sequence-specific primer -polymerase chain reaction, RFLP : restriction fragment
lengthpolymorphism
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The median anti -HBs antibody level was compared among the
SNP types of each cytokine gene, and was found to be lower in the
IL-10 (

1082) AG than AA type, but the difference was not signifi-
cant [Figure 1-a]. In the IL-10 (

819) CT type, a significant differ-
ence in the mean antibody level was observed compared with those
in the other types (CC/TT) (P0.05) [Figure 1-b]. The anti -HBs
antibody production level was significantly lower in the TNF-α
(

857) CC than CT type (P0.05) [Figure 1-c]. The TNF-α (

308)
GA type was detected in only 2 subjects in the present study ; how-
ever, their anti -HBs antibody levels of 1.1 and 55.9 mIU/ml were
lower than the mean level (465.0 mIU/ml) of the GG type. No other
investigated SNP type influenced the anti -HBs antibody produc-
tion level (data not shown).
Based on multiple regression analyses with the low antibody
level group (10 mIU/ml), the anti -HBs antibody was not readily
produced in the IL-10 (

1082) AG and TNF-α (

857) CC haplo-
type (P0.05). Conversely, the antibody was readily produced
in the IL-10 (

1082) AA and TNF-α (

857) CC haplotype, and
the IL-10 (

1082) AA and TNF-α (

857) CT haplotype (P0.05)
[Figure 2]. Table 3 shows multiple regression analysis data for
the IL-10 (





Table 2 Association of IL-10, TNF-α, and IFN-γ SNPs genotype frequencies in vaccinated students with outcomes of anti -HBs titer groups, and














ancestral allele : A
AA 14 30 49
0.016 0.123AG 12 5 13




ancestral allele : C
CC 2 1 10
0.055 0.347CA 18 17 26




ancestral allele : C
CC 2 1 8
0.141 0.110CA 18 17 29




ancestral allele : C
CC 22 28 37
0.013 0.057CT 4 6 26




ancestral allele : A
AA 20 25 43
0.836 0.066AG 6 10 19
GG 0 0 0
IFN-γ (+874) : rs2430561
ancestral allele : A
AA 21 28 50
0.780 0.728AT 5 6 12
TT 0 1 0
Significant associations (P0.05) are in bold.
Figure 1. Distribution of anti

HBs antibody titers. a : Distribution of anti

HBs antibody titers in IL-10 (

1082) AA and AG types(Mann-Whitney
test). b : Distribution of anti

HBs antibody titers in IL-10 (

819) CC, CT, and TT types(Kruskal -Wallis test ; P0.05). c : Distribution of anti

HBs
antibody titers in TNF-α (

857) CC and CT types(Mann-Whitney test). In all the figures, central horizontal lines show the median. NS : non-
significant.
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Haplotype analysis of IL-10 SNPs showed the linkage disequilib-
rium between IL-10 (

819) and IL-10 (

592) had values of D’=





819) had values of D’=0.349, r2=0.031, LOD=0.61, and IL-10
(

1082) and IL-10 (

592) had values of D’=0.448, r2=0.053, LOD=
1.05.
DISCUSSION
It has been reported that the functions of type 1 (Th1) and 2
(Th2) helper T cells cytokines were altered in HB vaccine non-
responders (19). Hyodo et al. (20) reported that stimulation using
HBV core antigen increases production of the Th2-related cytokine,
IL-10, and is involved in persistent HBV infection. Miyazoe et al.
(21) reported that the IL-10 (

592) CC type is involved in elimina-
tion of HBV. Furthermore, Rahman et al. (22) reported that HBs
antigen- induced IFN-γ production tended to be low in peripheral
blood mononuclear cells in HB vaccine non-responders. In a study
on cytokine-dependent antiviral action of CD4-positive T cells in
the treatment of chronic hepatitis B patients with HB vaccine,
HBV-DNA was significantly decreased in patients with high lev-
els of IFN-γ and TNF-α production. These findings reveal that
HB vaccine does not induce CD8-positive Tcell proliferation, i.e.,
HB vaccine induces IFN-γ and TNF-α production by stimulation
of Th1, and exhibits antiviral action by reducing HBV-DNA by
antibody production (23).
It has been reported that IFN-γ production by peripheral blood
mononuclear cells in response to HBs antigen stimulation was de-
creased in HB vaccine non-responders (22). We investigated
IFN-γ SNPs rs2430561 (+874) and rs2069727 (3’ -untranslated
region ; UTR), which are likely to influence IFN-γ production level
and has been suggested to be involved in the 3’ transcriptional
regulatory region of the IFN-γ gene in the immune response to HB
vaccine (16) ; however, no involvement of these SNPs in the anti -
HBs antibody production level was observed. The IFN-γ signal
may influence the immune response to HB vaccine by the previous
our study (24), thus, it is necessary to investigate factors that may
influence anti -HBs antibody production by regulating IFN-γ pro-
duction.
SNPs present in the IL-10 gene promoter region have been sug-
gested to be involved in the immune response to HB vaccine, and
a study on the association between the IL-10 SNPs and response
to HB vaccine suggested involvement of IL-10 (

1082) (13). We
also observed a similar tendency ; the frequency of the IL-10 (

1082)
AG type was significantly higher in the low antibody level group,
suggesting its association with the level of immune response to the
vaccine. Höhler et al. (13) reported that the Ets-binding sequence
is present in the IL-10 (

1082) A/G region, and that the major
allele, A, has a stronger binding ability to the inhibitory transcrip-
tion regulator PU.1 compared with that of the minor allele, G,
resulting in inhibition of IL-10 expression. They also reported that
Figure 2. The ratio of low-responders and responders in IL-10(

1082) and TNF-α (

857) genotypes. NS : non-significant. (Multiple regression
analysis)
Table 3 Results of multiple regression analysis for the IL-10 (

1082) AG and TNF-α (

857) CT types.






0.33 0.16 2.04 0.043
TNF-α(

857) CT type 0.40 0.15 2.63 0.010
β : Standardized partial regression coefficient (β -weight).
SE(β) : Standard error of the β -weight. T value : significance of the β -weight.
Significant associations (P0.05) are in bold.
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592), decreases IL-10 gene transcription
activity and interferes with IFN-γ inhibition by IL-10, promoting
anti -HBs antibody production. We evaluated the value of D’, r2,
and LOD of the haplotypes. The results of linkage disequilibrium
analysis in Japanese subjects reveal IL-10 (

819) was in strong
linkage disequilibrium with IL-10 (

592), suggesting their pres-







1082), and IL-10 (

592) were not present
on the same haplotype block. These findings suggest that the
response to HB vaccine can be estimated based on solely on the
IL-10 (

1082) in Japanese subjects. We hypothesize that this SNP
influences transcription regulation and changes the IL-10 gene
expression level, influencing anti -HBs antibody production and
altering responsiveness to the vaccine. Höhler et al. (13) sug-
gested that because IL-10 is a Th1 cell - inhibitory cytokine, a
pathway that changes the IL-10 expression level may influence
HBs antibody production. Our study found a tendency for a low
anti -HBs antibody level in the IL-10 (

819) CT type, suggesting
that IL-10 plays an important role in the immune response to HB
vaccine.
An association between TNF-α (

308) and unresponsiveness
to HB vaccine has previously been reported (14). The TNF-α
(

308) GA type was found to influence TNF-α gene expression,
reducing the anti -HBs antibody level. Kroeger et al. (25) reported
that the TNF-α (

308) minor allele A increases TNF-α gene tran-
scription activity. However, the frequency of the TNF-α (

308)
allele A is very low in the Japanese population, and the GA type
was detected in only 2 subjects in the present study. A low anti -
HBs antibody level in these 2 subjects suggests that this allele
may be able to influence on the immune response to HB vaccine. In
our study, the antibody level was significantly higher in the hetero
CT type than in the major homo CC type of the TNF-α (

857) C/T
polymorphism of the TNF-α gene transcription regulatory region.
This SNP is also a polymorphism in the gene promoter region and
may influence the gene expression level. Qiu et al. (26) reported
that the TNF-α (

857) CT type of the TNF-α gene promoter re-
gion changes the TNF-α gene expression level and influences the
progression of hepatitis B pathology. The authors suggested that
HB vaccination promotes anti -HBs antibody production in TNF-α
(

857) CT type patients via high TNF-α expression, resulting in
resistance to the progression of hepatitis B. A similar finding was
reported by Kim et al. (27) in a study involving hepatitis B patients
in Korea. These findings provide support for the involvement of
TNF-α in anti -HBs antibody production after HB vaccination, and
indicate the need for further detailed investigation of the influence
of racial differences in genetic factors. Our findings are the first
report of the association between TNF-α (

857) CT type and im-
mune response to HB vaccine.
Inheritance of the IL-10 (

1082) and TNF-α (

857) types are
genetic factors influencing HBs antibody production in the Japa-
nese population. Further studies with a greater number of subjects
may contribute to a better understanding of the influence of cy-
tokine gene polymorphisms and expression of cytokines on the
humoral immune response to HBsAg vaccination. Well -designed
investigations with representing different ethnicities are warranted
to confirm our findings.
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